David Dodds
Presidente presso Sucampo Pharma Europe Ltd.
Posizioni attive di David Dodds
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Presidente | 15/09/2009 | - |
| Corporate Officer/Principal | 07/08/2008 | 15/09/2009 |
Storia della carriera di David Dodds
Formazione di David Dodds
| University of Sunderland | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Settori
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
- Borsa valori
- Insiders
- David Dodds
- Esperienza
